These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26011445)

  • 1. Distribution of citrate and citrate infusion rate during donor plasmaphereses.
    Evers J; Taborski U
    J Clin Apher; 2016 Feb; 31(1):59-62. PubMed ID: 26011445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of saline infusion and citrate infusion rate during donor plasmapheresis.
    Evers J; Schreiber GB; Taborski U
    J Clin Apher; 2022 Dec; 37(6):584-591. PubMed ID: 36314778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report on 50 cases of severe acute hypotension at donor plasmaphereses: treatment and course.
    Evers J; Schreiber GB; Taborski U
    Int J Artif Organs; 2017 May; 40(5):230-233. PubMed ID: 28525673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective trial assessing the safety and efficacy of collecting up to 840 mL of plasma in conjunction with saline infusion during plasmapheresis.
    Buzza M; Marks DC; Capper H; Cassin E; Badcock CA; Reid S; Kwok M; Yang H; Lee J; Corrigan C; Hartkopf-Theis T; Keller A
    Transfusion; 2012 Aug; 52(8):1806-13. PubMed ID: 22348664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin G levels during collection of large volume plasma for fractionation.
    Burkhardt T; Rothe R; Moog R
    Transfus Apher Sci; 2017 Jun; 56(3):417-420. PubMed ID: 28454884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation, bleeding, and clotting at donor plasmapheresis.
    Evers J; Taborski U
    J Clin Apher; 2018 Aug; 33(4):538-540. PubMed ID: 29575131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Plasma Unit Weight and Donor Sex on Post-Donation Citrate Level: An Experimental Study on Plasmapheresis Donors.
    Marraccini C; Schiroli D; Mancuso P; Molinari G; Razzoli A; Gavioli G; Fasano T; Baricchi R; Rossi PG; Merolle L
    Transfus Med Hemother; 2023 Dec; 50(6):491-501. PubMed ID: 38089491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of citrate anticoagulation during plasma exchange with different replacement solutions.
    Antonic M; Gubensek J; Buturović-Ponikvar J; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):322-6. PubMed ID: 19695068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate for long-term hemodialysis: prospective study of 1,009 consecutive high-flux treatments in 59 patients.
    Apsner R; Buchmayer H; Gruber D; Sunder-Plassmann G
    Am J Kidney Dis; 2005 Mar; 45(3):557-64. PubMed ID: 15754278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plateletpheresis with the IBM model 2997. I. Effects of ACD, NIH formula B on selected donor indices.
    Mishler JM; Lund P; Borberg H
    Vox Sang; 1980; 38(1):36-9. PubMed ID: 7376565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanical donor plasmapheresis using the Haemonetics Ultralite plasma collection system. 1. Collection of fresh plasma].
    Matthes G; Pawlow I; Richter E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):343-8. PubMed ID: 2475417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac arrest following injection of concentrated trisodium citrate.
    Punt CD; Boer WE
    Clin Nephrol; 2008 Apr; 69(4):317-8. PubMed ID: 18397711
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of citrate concentration on the quality of plasma obtained by automated plasmapheresis: a prospective study.
    Beeck H; Becker T; Kiessig ST; Kaeser R; Wolter K; Hellstern P
    Transfusion; 1999; 39(11-12):1266-70. PubMed ID: 10604256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
    Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
    Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulation for plasmapheresis].
    Amemiya H; Sekihara H; Kobayashi T; Koiwa F; Niikura K
    Nihon Rinsho; 2004 May; 62 Suppl 5():323-7. PubMed ID: 15197938
    [No Abstract]   [Full Text] [Related]  

  • 19. Aluminum content of source plasma and sodium citrate anticoagulant.
    May JC; Rains TC; Yu LJ; Etz NM
    Vox Sang; 1992; 62(2):65-9. PubMed ID: 1519369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.